SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-22-026588
Filing Date
2022-10-19
Accepted
2022-10-19 07:58:37
Documents
14
Period of Report
2022-10-19
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K abt-20221019.htm   iXBRL 8-K 35811
2 EX-99.1 abt-20221019xexhibitx991.htm EX-99.1 582777
6 imagea.jpg GRAPHIC 1317
  Complete submission text file 0001628280-22-026588.txt   788369

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abt-20221019.xsd EX-101.SCH 1881
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abt-20221019_lab.xml EX-101.LAB 23832
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abt-20221019_pre.xml EX-101.PRE 12495
8 EXTRACTED XBRL INSTANCE DOCUMENT abt-20221019_htm.xml XML 11292
Mailing Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500
Business Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500 2246676100
ABBOTT LABORATORIES (Filer) CIK: 0000001800 (see all company filings)

IRS No.: 360698440 | State of Incorp.: IL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-02189 | Film No.: 221317240
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences